NASHP’s drug rate-setting legislation enables states to establish price “ceilings” for high-cost drugs. Under the law, a state drug cost review commission, with information provided by an advisory board, would establish the maximum amount that payers would pay for individual drugs. While transparency laws expose the true cost of drugs, rate-setting regulations take the next step to protect consumers and payers from over-priced drugs.
NASHP works with states to advance rate-setting legislation and will continue to track and report on those efforts at its Center for State Rx Drug Pricing. NASHP has prepared additional guides and background material specifically for state lawmakers and officials interested in this model legislation. Please contact Jennifer Reck if you wish to receive this state-only material.
Read the latest on prescription drug rate-setting initiatives below.